Using the dominant epitope of CD4 T cells, HpaA88-100, we have demonstrated that the immunodominant CD4 T cell response to HpaA88-100 reduced the risk of severe gastric diseases in an HLA-DRB1*1501-restricted population [5]. The gene discussed is CD4; the disease is stomach disorder.